Sonoma Pharmaceuticals's total assets for Q2 2026 were $13.86M, a decrease of -5.06% from the previous quarter. SNOA total liabilities were $10.07M for the fiscal quarter, a -4.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.